Why is Par Drugs & Che. falling/rising?

As of 25-Jul, Par Drugs & Chemicals Ltd is experiencing a decline in its stock price, currently at 110.18, which reflects a decrease of 2.25 or 2.0%. Despite today's performance showing that the stock outperformed its sector by 5.25%, it has a troubling long-term outlook, with a year-to-date return of -44.61% and a one-year return of -56.47%. The stock is trading at a discount compared to its peers, with a low debt-to-equity ratio and a return on equity of 13.8, indicating a potentially attractive valuation. However, the company's profits have fallen by 7.9%, and recent financial results show a significant decline in net sales and profit after tax, which may be contributing to the current price drop.
In the broader market context, the stock's short-term performance over the past week shows a gain of 3.75%, contrasting with the Sensex's decline of 0.53%. However, the stark difference in long-term performance, with the stock down significantly over one year while the Sensex has gained 1.77%, highlights the challenges faced by Par Drugs & Chemicals Ltd. The company's poor long-term growth metrics, including a low annual growth rate in net sales and operating profit over the last five years, further exacerbate investor concerns, leading to the stock's current downward trend.